Table 3.
Japan PMS demographics and baseline lesion characteristics
| Characteristic | DES | BMS | p value |
|---|---|---|---|
| Age (years) | 73.5 ± 8.5 (904) | 73.8 ± 8.7 (190) | 0.68 |
| Gender | 0.79 | ||
| Male | 70.2% (635/904) | 71.6% (136/190) | |
| Female | 29.8% (269/904) | 28.4% (54/190) | |
| Diabetes | 58.7% (531/904) | 48.9% (93/190) | 0.015 |
| Diabetes type | 0.28 | ||
| Type I | 8.3% (43/518) | 4.4% (4/90) | |
| Type II | 91.7% (475/518) | 95.6% (86/90) | |
| Hypercholesterolemia | 61.0% (551/904) | 50.0% (95/190) | 0.006 |
| Hypertension | 85.5% (773/904) | 78.4% (149/190) | 0.021 |
| Carotid disease | 58.3% (527/904) | 45.3% (86/190) | 0.001 |
| Renal disease | 43.6% (394/904) | 40.5% (77/190) | 0.47 |
| Chronic renal failure | 35.8% (323/903) | 34.7% (66/190) | 0.80 |
| Pulmonary disease | 7.5% (68/904) | 6.8% (13/190) | 0.88 |
| Smoking status | 0.11 | ||
| Never | 36.5% (330/904) | 33.2% (63/190) | |
| Quit | 45.0% (407/904) | 41.6% (79/190) | |
| Still smokes | 18.5% (167/904) | 25.3% (48/190) | |
| Rutherford 0–3 | 77.9% (663/851) | 65.7% (115/175) | < 0.001 |
| Rutherford 4–6 | 22.1% (188/851) | 34.3% (60/175) | |
| Lesion length (mm) | 14.6 ± 9.6 (1088) | 11.1 ± 8.4 (202) | < 0.001 |
| Total occlusion | 41.3% (450/1089) | 35.1% (71/202) | 0.10 |
| RVD (mm) | 5.7 ± 0.9 (1088) | 5.7 ± 0.9 (202) | 0.77 |
| Percent diameter stenosis (%) | 91.7 ± 10.8 (1089) | 91.6 ± 10.1 (202) | 0.93 |
| Calcification | 0.021 | ||
| None | 26.8% (292/1089) | 29.2% (59/202) | |
| Little | 34.9% (380/1089) | 41.6% (84/202) | |
| Moderate | 21.0% (229/1089) | 19.8% (40/202) | |
| Severe | 17.3% (188/1089) | 9.4% (19/202) | |
| Patent runoff vessels | 0.34 | ||
| 0 | 6.6% (71/1083) | 10.0% (20/201) | |
| 1 | 31.9% (345/1083) | 31.3% (63/201) | |
| 2 | 32.7% (354/1083) | 29.4% (59/201) | |
| 3 | 28.9% (313/1083) | 29.4% (59/201) | |
| In-stent restenosis | 18.9% (206/1089) | 7.9% (16/202) | < 0.001 |
Numbers in parentheses represent number of patients or number of lesions as appropriate